Radium-223 re-treatment from an international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases

Radium-223 re-treatment from an international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 27; p. vi255
Main Authors: Sartor, O., Heinrich, D., Mariados, N., Vidal, M.J. Méndez, Keizman, D., Karlsson, C. Thellenberg, Peer, A., Procopio, G., Frank, S.J., Pulkkanen, K.J., Rosenbaum, E., Severi, S., Perez, J.M. Trigo, Wagner, V., Garcia-Vargas, J., Li, R., Nordquist, L.T.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw372.36